NSEReply to Clarification- Financial results2d ago · 27 Jul 2026, 01:27 pm
Reply to Clarification- Financial results
Alpa Laboratories Limited · ALPA
✦ AI SummaryResults
Alpa Laboratories Limited has responded to a clarification request from the Exchange regarding its financial results for the quarter ended 31-Mar-2026, as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
The Exchange had sought clarification from Alpa Laboratories Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
Attachments (1)
📄pdf
Download →
ALPA_24072026153658_Clarification_Letter.pdf
View document text
Date of 23-Jul-2026
NSE Acknowledgement
Symbol :- ALPA
Name of the Company : - Alpa Laboratories Limited
Module :- Integrated Filing- Non-Banking Ind AS
Submission Type :- Revision
Quarter/Period Ended :- 31-Mar-2026
Date of Submission :- 23-Jul-2026 16:25:19
NEAPS App. No :- 177314
Disclaimer :We acknowledge the receipt of your submission through NEAPS. The information provided by you has been
disseminated on the website on as is basis.
BSE LTD
ACKNOWLEDGEMENT
Acknowledgement No : 2307202605431527 Date & Time : 23/07/2026 04:25:19 PM
Scrip Code : 532878
Entity Name : ALPA LABORATORIES LIMITED
Compliance Type : Regulation 33(3)-Integrated Finance Ind AS
Quarter / Period : 31/03/2026
Mode : Revised XBRL E-Filing